Scaffold-Mediated Cellular and Acellular Delivery of Inducible BMP2-Lentivirus Promotes Atrophic Nonunion Fracture Healing without Heterotopic Ossification

Nonunions occur in 5-10% of fracture patients, and current treatments are expensive with variable success. Controllable, localized delivery of BMP2 using porous, degradable scaffolds may be a promising alternative. We designed tube-shaped cryogel scaffolds (chitosan-gelatin, CG; chitosan-agarose-gelatin, CAG) to deliver a doxycycline-inducible BMP2-lentivirus vector (BMP2-LV). Results showed that CAG scaffolds have larger pores, higher toughness, and better cell infiltration than CG scaffolds. When scaffolds were implanted subcutaneously in mice and treated with continuous doxycycline, x-ray radiographs and microCT showed mineralization in scaffolds seeded with adipose-derived stem cells (BMP2-LV-ASC) but not acellular scaffolds (BMP2-LV) 4-weeks after implantation. Scaffolds that were implanted at the site of an established femoral nonunion 4-weeks after fracture and treated with continuous doxycycline showed improved healing with CG/CAG BMP2-LV and BMP2-LV-ASC compared to scaffold-only controls. At 2-weeks post implantation, microCT and histology showed that BMP2-expressing scaffolds promoted increased callus mineralization relative to scaffold-only. At 8-weeks post implantation, microCT and histology showed near-complete bone bridging in BMP2-treated groups compared to still visible fracture lines in the scaffold-only groups. However, CG/CAG BMP2-LV-ASC groups also showed heterotopic ossification. Finally, we demonstrated that heterotopic ossification was eliminated at 8-weeks post implantation in CG BMP2-LV-ASC groups by restricting doxycycline treatment to the first 3 days after implantation. We conclude that lentiviral BMP2 delivery using cellularized and acellular cryogel scaffolds enhanced fracture healing in a nonunion model, and that a 3-day period of BMP2 induction using an inducible system was sufficient to promote healing without the complication of heterotopic ossification.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-19
DOI
https://doi.org/10.64898/2026.11.18.767681
Primary Topic
Bone Tissue Engineering Materials
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Scaffold-Mediated Cellular and Acellular Delivery of Inducible BMP2-Lentivirus Promotes Atrophic Nonunion Fracture Healing without Heterotopic Ossification

Katherine R. Hixon, Matthew J. Silva, Tiffany Lee, Farshid Guilak et al.
bioRxiv (Cold Spring Harbor Laboratory)
Bone Tissue Engineering Materials
preprint

Scaffold-Mediated Cellular and Acellular Delivery of Inducible BMP2-Lentivirus Promotes Atrophic Nonunion Fracture Healing without Heterotopic Ossification

Katherine R. Hixon, Matthew J. Silva, Tiffany Lee, Farshid Guilak, Andre F. Coello, Yu Seon Kim, Mariam Obaji, Nicole Gould, Leyi Chen
preprint en

Abstract

Nonunions occur in 5-10% of fracture patients, and current treatments are expensive with variable success. Controllable, localized delivery of BMP2 using porous, degradable scaffolds may be a promising alternative. We designed tube-shaped cryogel scaffolds (chitosan-gelatin, CG; chitosan-agarose-gelatin, CAG) to deliver a doxycycline-inducible BMP2-lentivirus vector (BMP2-LV). Results showed that CAG scaffolds have larger pores, higher toughness, and better cell infiltration than CG scaffolds. When scaffolds were implanted subcutaneously in mice and treated with continuous doxycycline, x-ray radiographs and microCT showed mineralization in scaffolds seeded with adipose-derived stem cells (BMP2-LV-ASC) but not acellular scaffolds (BMP2-LV) 4-weeks after implantation. Scaffolds that were implanted at the site of an established femoral nonunion 4-weeks after fracture and treated with continuous doxycycline showed improved healing with CG/CAG BMP2-LV and BMP2-LV-ASC compared to scaffold-only controls. At 2-weeks post implantation, microCT and histology showed that BMP2-expressing scaffolds promoted increased callus mineralization relative to scaffold-only. At 8-weeks post implantation, microCT and histology showed near-complete bone bridging in BMP2-treated groups compared to still visible fracture lines in the scaffold-only groups. However, CG/CAG BMP2-LV-ASC groups also showed heterotopic ossification. Finally, we demonstrated that heterotopic ossification was eliminated at 8-weeks post implantation in CG BMP2-LV-ASC groups by restricting doxycycline treatment to the first 3 days after implantation. We conclude that lentiviral BMP2 delivery using cellularized and acellular cryogel scaffolds enhanced fracture healing in a nonunion model, and that a 3-day period of BMP2 induction using an inducible system was sufficient to promote healing without the complication of heterotopic ossification.

bioRxiv (Cold Spring Harbor Laboratory)
Dartmouth College (US), Washington University in St. Louis (US), Shriners Hospitals for Children (US)
Bone Tissue Engineering Materials
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon